Commonwealth Equity Services
TARS icon

Commonwealth Equity Services’s Tarsus Pharmaceuticals TARS Stock Holding History

Commonwealth Equity Services’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03M Sell
79,888
-1,004
-1% -$64.1K 0.01% 1387
2026
Q1 		$5.67M Buy
80,892
+12,597
+18% +$880K 0.01% 1245
2025
Q4 		$5.59M Buy
68,295
+1,341
+2% +$100K 0.01% 1240
2025
Q3 		$3.98M Sell
66,954
-12,897
-16% -$635K 0.01% 1513
2025
Q2 		$3.23M Buy
79,851
+8,259
+12% +$372K ﹤0.01% 1645
2025
Q1 		$3.68M Buy
+71,592
New +$3.54M 0.01% 1489

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Commonwealth Equity Services's TARS Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Tarsus Pharmaceuticals (TARS) stake by 1.2% in Q2 2026, selling an estimated $64.1K and leaving 79,888 shares worth $5.03M. The position accounts for 0.01% of the portfolio, ranked #1387.

Commonwealth Equity Services first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.67M in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Commonwealth Equity Services held 79,888 shares of Tarsus Pharmaceuticals worth $5.03M as of Q2 2026.
  • Commonwealth Equity Services sold 1,004 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $64.1K.
  • Tarsus Pharmaceuticals made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1387 holding.
  • Commonwealth Equity Services first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Commonwealth Equity Services's Tarsus Pharmaceuticals position peaked at $5.67M in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.